Pharmaceutical Analytical Services Outsourcing in India: Cost Savings, Product Quality and Shorter Delivery Times are Key Drivers - GBI Research Reports

Pharmaceutical Analytical Services Outsourcing in India: Cost Savings, Product Quality and Shorter Delivery Times are Key Drivers

Pharmaceutical Analytical Services Outsourcing in India: Cost Savings, Product Quality and Shorter Delivery Times are Key Drivers - GBI Research Reports
Pharmaceutical Analytical Services Outsourcing in India: Cost Savings, Product Quality and Shorter Delivery Times are Key Drivers
Published Nov 12, 2010
65 pages — Published Nov 12, 2010
Price US$ 3,500.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

GBI Research's medical devices report, 'Pharmaceutical Analytical Services Outsourcing in India: Cost Savings, Product Quality and Shorter Delivery Times are Key Drivers' provides key data, information and analysis on the pharmaceutical analytical services outsourcing in india. The report provides market landscape, competitive landscape and market trends information on the segments within the analytical services market. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape, services technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

Scope

- Key geographies covered is India
- Market size and company share data the segments with pharmaceutical anlaytical laboratories market
- Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2009.
- Qualitative analysis of key market trends, market drivers, and restraints by each category within the pharmaceutical analytical services market.
- The report also covers information on the leading market players, the competitive landscape, services and technologies.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the Indian pharmaceutical analytical services market.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the promising products
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What's the next being thing in the pharmaceutical analytical services market? - Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the Indian pharmaceutical analytical services market and the factors shaping it.

  
Source:
Document ID
GBIME0014MR
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
1 Table of Contents43
1.1 List of Tables61
1.2 List of Figures61
2 Introduction72
2.1 GBI Research Report Guidance81
3 Background:92
3.1 Major Services under Pharmaceutical Analytical Services101
3.1.1 Impurity Profile101
3.1.2 Analytical Method Development and Validations101
3.1.3 Particle Size Distribution101
4 Pharmaceutical Drug Discovery Outsourcing Market: Market Characterization115
4.1 Market Share and Market Size111
4.2 Pharmaceutical Drug Discovery Outsourcing Market, India, Revenue ($bn), 2004-2009111
4.3 Pharmaceutical Drug Discovery Outsourcing Market, India, Revenue ($bn), 2009-2016122
4.4 Forces that Drive Drug Discovery in India and China141
4.4.1 Declining R&D Productivity, Especially for Big Pharma142
5 Outsourcing Plan for Pharmaceutical Companies168
5.1 Why India and China?181
5.1.1 Availability of Skilled Manpower181
5.1.2 Improved IP Protection in India and China191
5.1.3 Government Support for Drug Discovery Development201
5.1.3.1 Hutchison MediPharma with Merck KGaA and Eli Lilly &Co201
5.1.3.2 Advinus Therapeutics with Ortho-McNeil-Janssen Pharmaceutical Inc, Genzyme Corporation and Merck &Co211
5.1.3.3 Ranbaxy with Merck &Co and GlaxoSmithKline211
5.1.4 SWOT Analysis of the Drug Discovery Industry in India221
5.1.5 Conclusion231
6 IP Protection in India and China Improved IP Protection to Encourage Innovation245
Patent Act 2005 First Step towards Improving IP Protection251
6.2 IPR Enforcement Rules, 2007261
6.3 Trademarks Bill 2007261
6.4 Drugs and Cosmetics Act (Amendment) 2008271
6.5 EIPR (Enforcers of Intellectual Property Rights) Ensuring IPR Laws Implementation in India272
7 Government and Regulatory Support in India Strong Support to Research Institutes and Small Companies294
7.1 Government/Regulatory Support for Drug Discovery in India291
7.1.1 Open Source Drug Discovery291
7.1.2 Drug Development Promotion Board: Encouraging a PPP Model for Drug Discovery and Development301
7.1.3 Technology Development Board: Supporting Technology Oriented Projects 311
7.1.4 NMITLI (New Millennium Indian Technology Leadership Initiative) Scheme321
8 Pharmaceutical Analytical Services Outsourcing Market, Market Dynamics332
8.1 Pharmaceutical Analytical Services Outsourcing Market, Market Trends331
8.1.1 Pricing Pressures Driving Outsourcing of Pharmaceutical Analytical Work to Low Cost Destinations331
8.1.2 Flexibility Offered by Companies in Terms of Resource and Manpower Allocation Contributing Towards Increased Outsourcing331
8.1.3 Shared Risk Concept Encourages Greater Outsourcing of Drug Development 331
8.2 Pharmaceutical Analytical Services Outsourcing Market, Market Drivers331
Lower Cost is a Key Driver towards Chemistry Outsourcing to Asian CROs331
8.2.2 Demand for Shorter Research Cycle Driving Outsourcing of Chemistry Services341
8.3 Pharmaceutical Analytical Services Outsourcing Market, Market Restraints341
8.3.1 Intellectual Property and Legal Landscape is a Key Restraint in the Growth of Outsourcing of Pharmaceutical Analytical Services to Asian Countries341
9 Market Opportunity and Risk Assesment351
10 Future Outlook362
11 Major Indian Drug Discovery Companies Different Business Models to Provide Similar Services3813
11.1 Indian Drug Discovery Business Model R&D Hive-off for Better Services and Risk Reduction381
11.2 Jubilant Organosys Jubilant Biosys391
11.2.1 About Jubilant Organosys391
11.2.2 Major Drug Discovery Deals401
11.3 Dr. Reddy s Aurigene411
11.3.1 About Dr. Reddy s411
11.3.2 Aurigene411
11.3.3 Major Drug Discovery Deals421
11.4 Biocon s Syngene431
11.4.1 About Biocon431
11.4.2 Syngene431
11.4.3 Major Drug Discovery Deals441
11.5 GVK BIO451
11.5.1 Business Description451
11.5.2 Major Drug Discovery Deals461
11.6 Advinus Therapeutics471
11.6.1 Business Description471
11.6.2 Major Drug Discovery Deals481
11.7 Sipra Labs491
11.7.1 Business Description491
11.8 Sai Advantium501
11.8.1 Business Description501
12 Deals Analysis Equal Thrust From Big Pharma and Mid-Size Pharma516
12.1 Number of Discovery Research Deals Increased Activity by Big and Mid-size Pharma511
12.2 Deals by Major Therapeutic Area Oncology and Metabolic Disorders 521
12.3 Deals by Client Type Mid-size Pharma Deals Rising in India and China 532
12.4 Major Drug Discovery Deals551
12.4.1 Amgen with Jubilant Biosys: Supporting Early Stage Preclinical Development Effort to Provide Cost-Effective Drugs551
12.4.2 Bristol-Myers Squibb with Syngene: Dedicated Research Facility for Discovery and Early Drug Development551
12.4.3 Novartis with Aurigene: Generating Pre-clinical Candidates for Oncology-focused Program551
12.4.4 Merck &Co with Advinus Therapeutics: To Develop Clinically Validated Drug Candidates for Metabolic Disorders551
12.5 Conclusion561
13 Future Challenges Financial and Intellectual Obstacles to Impede the Future Growth573
13.1 Financial Problems will Make it Difficult to Sustain the Growth571
13.2 Talent Shortage in Early Stage Chemistry and Biology571
13.3 Competition from Europe as an Alternative Discovery Research Destination581
13.4 Conclusion591
14 Key Takeaway601
15 Appendix615
15.1 Definitions611
15.2 Market Definitions611
15.3 Acronyms613
15.4 Research Methodology642
15.4.1 Secondary Research641
15.4.2 Primary Research641
15.4.3 Models651
15.4.4 Forecasts651
15.4.5 Expert Panels651
15.5 Contact Us651
15.6 Disclaimer651

Table Of Contents

GBI Research Reports—GBI Research covers worldwide markets and issues, supplies actionable data and forecasts and is driven by industry leaders' insights. GBI Research provides a broad spectrum of reports across the healthcare and energy industries and its online offering is easy to navigate - a comprehensive resource for business information needs.

About the Author


Cite this Report

  
MLA:
GBI Research Reports. "Pharmaceutical Analytical Services Outsourcing in India: Cost Savings, Product Quality and Shorter Delivery Times are Key Drivers" Nov 12, 2010. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GBI-Research-Reports/Pharmaceutical-Analytical-Services-Outsourcing-in-India-Cost-Savings-Product-Quality-and-Shorter-Delivery-Times-are-Key-Drivers-2115-111>
  
APA:
GBI Research Reports. (2010). Pharmaceutical Analytical Services Outsourcing in India: Cost Savings, Product Quality and Shorter Delivery Times are Key Drivers Nov 12, 2010. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GBI-Research-Reports/Pharmaceutical-Analytical-Services-Outsourcing-in-India-Cost-Savings-Product-Quality-and-Shorter-Delivery-Times-are-Key-Drivers-2115-111>
  
US$ 3,500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.